Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain

被引:299
作者
Suzuki, H
Duncan, GS
Takimoto, H
Mak, TW
机构
[1] AMGEN INST, TORONTO, ON M5G 2C1, CANADA
[2] ONTARIO CANC INST, TORONTO, ON M5G 2C1, CANADA
[3] UNIV TORONTO, DEPT MED BIOPHYS, TORONTO, ON M5G 2C1, CANADA
[4] UNIV TORONTO, DEPT IMMUNOL, TORONTO, ON M5G 2C1, CANADA
关键词
D O I
10.1084/jem.185.3.499
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The interleukin-2 receptor beta chain (IL-2R beta) is expressed on a variety of hematopoietic cell types, including natural killer (NK) cells and nonconventional T lymphocyte subsets such as intestinal intraepithelial lymphocytes (IEL). However, the importance of IL-2R beta-mediated signaling in the growth and development of these cells has yet to be clearly established. We have investigated. IEL and NK cells in mice deficient for IL-2R beta and describe here striking defects in the development of these cells. IL-2R beta(-/-) mice exhibited an abnormal LEL cell population, characterized by a dramatic reduction in T cell receptor alpha beta CD8 alpha alpha and T cell receptor gamma delta lymphocytes. This selective decrease indicates that IEL can be classified into those whose development and/or differentiation is dependent on IL-2R beta function and those for which IL-2R beta-mediated signaling is not essential. NK cell development was also found to be disrupted in IL-2R beta-deficient mice, characterized by a reduction in NK1.1(+)CD3(-) cells in the peripheral circulation and an absence of NK cytotoxic activity in vitro. The dependence of NK cells and certain subclasses of IEL cells on IL-2R beta expression points to an essential role for signaling through this receptor, presumably by IL-2 and/or IL-15, in the development of lymphocyte subsets of extrathymic origin.
引用
收藏
页码:499 / 505
页数:7
相关论文
共 43 条
  • [1] HUMAN LYMPHOCYTES-B EXPRESS THE P75 COMPONENT OF THE INTERLEUKIN 2-RECEPTOR
    BEGLEY, CG
    BURTON, JD
    TSUDO, M
    BROWNSTEIN, BH
    AMBRUS, JL
    WALDMANN, TA
    [J]. LEUKEMIA RESEARCH, 1990, 14 (03) : 263 - 271
  • [2] INTERLEUKIN (IL)-15 IS A NOVEL CYTOKINE THAT ACTIVATES HUMAN NATURAL-KILLER-CELLS VIA COMPONENTS OF THE IL-2 RECEPTOR
    CARSON, WE
    GIRI, JG
    LINDEMANN, MJ
    LINETT, ML
    AHDIEH, M
    PAXTON, R
    ANDERSON, D
    EISENMANN, J
    GRABSTEIN, K
    CALIGIURI, MA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1395 - 1403
  • [3] CONLEY ME, 1992, ANNU REV IMMUNOL, V10, P215
  • [4] LYMPHOID DEVELOPMENT IN MICE WITH A TARGETED DELETION OF THE INTERLEUKIN-2 RECEPTOR-GAMMA CHAIN
    DISANTO, JP
    MULLER, W
    GUYGRAND, D
    FISCHER, A
    RAJEWSKY, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (02) : 377 - 381
  • [5] DJEU JY, 1993, J IMMUNOL, V150, P960
  • [6] EXPRESSION AND ROLE OF P75 INTERLEUKIN-2 RECEPTOR ON HUMAN MONOCYTES
    ESPINOZADELGADO, I
    ORTALDO, JR
    WINKLERPICKETT, R
    SUGAMURA, K
    VARESIO, L
    LONGO, DL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (05) : 1821 - 1826
  • [7] LINEAGE RELATIONSHIPS OF THE FETAL THYMOCYTE SUBSET THAT EXPRESSES THE BETA-CHAIN OF THE INTERLEUKIN-2 RECEPTOR
    FALK, I
    LEVELT, CN
    EICHMANN, K
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (12) : 3373 - 3376
  • [8] FUJIHASHI K, 1990, J IMMUNOL, V145, P2010
  • [9] GIORDA R, 1992, J IMMUNOL, V149, P1957
  • [10] IDENTIFICATION AND CLONING OF A NOVEL IL-15 BINDING-PROTEIN THAT IS STRUCTURALLY RELATED TO THE ALPHA-CHAIN OF THE IL-2 RECEPTOR
    GIRI, JG
    KUMAKI, S
    AHDIEH, M
    FRIEND, DJ
    LOOMIS, A
    SHANEBECK, K
    DUBOSE, R
    COSMAN, D
    PARK, LS
    ANDERSON, DM
    [J]. EMBO JOURNAL, 1995, 14 (15) : 3654 - 3663